Compounds > leflunomide

leflunomide and everolimus

leflunomide has been researched along with everolimus in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (62.50)	24.3611
2020's	3 (37.50)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bharate, SB; Raghuvanshi, R	1
Basu, G; John, GT; Mani, SE; Manipadam, MT; Mohapatra, A	1
Goodman, D; Hill, P; Jaw, J	1
Chen, HA; Chen, YW; Hsu, YH; Hung, LY; Lee, CH; Wu, MS; Wu, MY	1
Shirai, H; Tojimbara, T; Yamazaki, T	1
Basile, G; Delbue, S; Dolci, M; Favi, E; Ferrante, P; Ferraresso, M; Signorini, L; Ticozzi, R; Villani, S	1

Reviews

1 review(s) available for leflunomide and everolimus

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

7 other study(ies) available for leflunomide and everolimus

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections. Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases	2022
Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:10 Topics: Antineoplastic Agents; Everolimus; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Middle Aged; Proto-Oncogene Proteins c-akt; Sarcoma, Kaposi; Sirolimus; Transplantation, Homologous; Treatment Outcome	2011
Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy. Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:4 Topics: Aged; BK Virus; Drug Substitution; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Opportunistic Infections; Polyomavirus Infections; Time Factors; Treatment Outcome; Tumor Virus Infections; Viral Load	2017
Successful Treatment for BK Virus Nephropathy by Leflunomide in a Kidney Transplant Patient: A Case Report. Transplantation proceedings, 2019, Volume: 51, Issue:5 Topics: BK Virus; Everolimus; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leflunomide; Middle Aged; Mycophenolic Acid; Nephritis, Interstitial; Opportunistic Infections; Polyomavirus Infections; Transplantation, Homologous; Tumor Virus Infections	2019
Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients After Kidney Transplantation: A Case Series. The American journal of case reports, 2020, Nov-25, Volume: 21 Topics: Antiviral Agents; BK Virus; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leflunomide; Polyomavirus Infections; Tumor Virus Infections	2020
In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication. Transplantation proceedings, 2022, Volume: 54, Issue:7 Topics: Antiviral Agents; BK Virus; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Leflunomide; Mycophenolic Acid; Polyomavirus Infections; Sirolimus; Tacrolimus; Tumor Virus Infections; Viral Proteins	2022